img

Global Branded Generics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Branded Generics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules. 
Global Branded Generics market is projected to reach US$ 523.1 million in 2029, increasing from US$ 312 million in 2022, with the CAGR of 8.2% during the period of 2024 to 2029. Demand from Oncology and Cardiovascular Diseases are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Branded Generics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Segment by Type
Oral
Parenteral
Topical
Other

Segment by Application


Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Branded Generics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Branded Generics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Branded Generics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Branded Generics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Branded Generics introduction, etc. Branded Generics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Branded Generics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Branded Generics Market Overview
1.1 Branded Generics Product Overview
1.2 Branded Generics Market Segment by Type
1.2.1 Oral
1.2.2 Parenteral
1.2.3 Topical
1.2.4 Other
1.3 Global Branded Generics Market Size by Type
1.3.1 Global Branded Generics Market Size Overview by Type (2018-2029)
1.3.2 Global Branded Generics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Branded Generics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Branded Generics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Branded Generics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Branded Generics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Branded Generics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Branded Generics Sales Breakdown by Type (2018-2024)
2 Global Branded Generics Market Competition by Company
2.1 Global Top Players by Branded Generics Sales (2018-2024)
2.2 Global Top Players by Branded Generics Revenue (2018-2024)
2.3 Global Top Players by Branded Generics Price (2018-2024)
2.4 Global Top Manufacturers Branded Generics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Branded Generics Market Competitive Situation and Trends
2.5.1 Branded Generics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Branded Generics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Branded Generics as of 2022)
2.7 Date of Key Manufacturers Enter into Branded Generics Market
2.8 Key Manufacturers Branded Generics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Branded Generics Status and Outlook by Region
3.1 Global Branded Generics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Branded Generics Historic Market Size by Region
3.2.1 Global Branded Generics Sales in Volume by Region (2018-2024)
3.2.2 Global Branded Generics Sales in Value by Region (2018-2024)
3.2.3 Global Branded Generics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Branded Generics Forecasted Market Size by Region
3.3.1 Global Branded Generics Sales in Volume by Region (2024-2029)
3.3.2 Global Branded Generics Sales in Value by Region (2024-2029)
3.3.3 Global Branded Generics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Branded Generics by Application
4.1 Branded Generics Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiovascular Diseases
4.1.3 Diabetes
4.1.4 Neurology
4.1.5 Gastrointestinal Diseases
4.1.6 Others
4.2 Global Branded Generics Market Size by Application
4.2.1 Global Branded Generics Market Size Overview by Application (2018-2029)
4.2.2 Global Branded Generics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Branded Generics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Branded Generics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Branded Generics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Branded Generics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Branded Generics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Branded Generics Sales Breakdown by Application (2018-2024)
5 North America Branded Generics by Country
5.1 North America Branded Generics Historic Market Size by Country
5.1.1 North America Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Branded Generics Sales in Volume by Country (2018-2024)
5.1.3 North America Branded Generics Sales in Value by Country (2018-2024)
5.2 North America Branded Generics Forecasted Market Size by Country
5.2.1 North America Branded Generics Sales in Volume by Country (2024-2029)
5.2.2 North America Branded Generics Sales in Value by Country (2024-2029)
6 Europe Branded Generics by Country
6.1 Europe Branded Generics Historic Market Size by Country
6.1.1 Europe Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Branded Generics Sales in Volume by Country (2018-2024)
6.1.3 Europe Branded Generics Sales in Value by Country (2018-2024)
6.2 Europe Branded Generics Forecasted Market Size by Country
6.2.1 Europe Branded Generics Sales in Volume by Country (2024-2029)
6.2.2 Europe Branded Generics Sales in Value by Country (2024-2029)
7 Asia-Pacific Branded Generics by Region
7.1 Asia-Pacific Branded Generics Historic Market Size by Region
7.1.1 Asia-Pacific Branded Generics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Branded Generics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Branded Generics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Branded Generics Forecasted Market Size by Region
7.2.1 Asia-Pacific Branded Generics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Branded Generics Sales in Value by Region (2024-2029)
8 Latin America Branded Generics by Country
8.1 Latin America Branded Generics Historic Market Size by Country
8.1.1 Latin America Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Branded Generics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Branded Generics Sales in Value by Country (2018-2024)
8.2 Latin America Branded Generics Forecasted Market Size by Country
8.2.1 Latin America Branded Generics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Branded Generics Sales in Value by Country (2024-2029)
9 Middle East and Africa Branded Generics by Country
9.1 Middle East and Africa Branded Generics Historic Market Size by Country
9.1.1 Middle East and Africa Branded Generics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Branded Generics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Branded Generics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Branded Generics Forecasted Market Size by Country
9.2.1 Middle East and Africa Branded Generics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Branded Generics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mylan NV
10.1.1 Mylan NV Company Information
10.1.2 Mylan NV Introduction and Business Overview
10.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Mylan NV Branded Generics Products Offered
10.1.5 Mylan NV Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis AG Branded Generics Products Offered
10.2.5 Novartis AG Recent Development
10.3 Eva Pharmaceutical Industries
10.3.1 Eva Pharmaceutical Industries Company Information
10.3.2 Eva Pharmaceutical Industries Introduction and Business Overview
10.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eva Pharmaceutical Industries Branded Generics Products Offered
10.3.5 Eva Pharmaceutical Industries Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Branded Generics Products Offered
10.4.5 Pfizer Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sun Pharmaceutical Industries Branded Generics Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Aspen Pharmacare Holding
10.6.1 Aspen Pharmacare Holding Company Information
10.6.2 Aspen Pharmacare Holding Introduction and Business Overview
10.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Aspen Pharmacare Holding Branded Generics Products Offered
10.6.5 Aspen Pharmacare Holding Recent Development
10.7 Abbott Laboratories
10.7.1 Abbott Laboratories Company Information
10.7.2 Abbott Laboratories Introduction and Business Overview
10.7.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbott Laboratories Branded Generics Products Offered
10.7.5 Abbott Laboratories Recent Development
10.8 Bausch Health
10.8.1 Bausch Health Company Information
10.8.2 Bausch Health Introduction and Business Overview
10.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bausch Health Branded Generics Products Offered
10.8.5 Bausch Health Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Branded Generics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Branded Generics Industrial Chain Analysis
11.4 Branded Generics Market Dynamics
11.4.1 Branded Generics Industry Trends
11.4.2 Branded Generics Market Drivers
11.4.3 Branded Generics Market Challenges
11.4.4 Branded Generics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Branded Generics Distributors
12.3 Branded Generics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Parenteral
Table 3. Major Company of Topical
Table 4. Major Company of Other
Table 5. Global Branded Generics Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Branded Generics Sales by Type (2018-2024) & (K MT)
Table 7. Global Branded Generics Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Branded Generics Sales by Type (2018-2024) & (US& Million)
Table 9. Global Branded Generics Market Share in Value by Type (2018-2024)
Table 10. Global Branded Generics Price by Type (2018-2024) & (USD/MT)
Table 11. Global Branded Generics Sales by Type (2024-2029) & (K MT)
Table 12. Global Branded Generics Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Branded Generics Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Branded Generics Sales Market Share in Value by Type (2024-2029)
Table 15. Global Branded Generics Price by Type (2024-2029) & (USD/MT)
Table 16. North America Branded Generics Sales by Type (2018-2024) & (K MT)
Table 17. North America Branded Generics Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Branded Generics Sales (K MT) by Type (2018-2024)
Table 19. Europe Branded Generics Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Branded Generics Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Branded Generics Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Branded Generics Sales (K MT) by Type (2018-2024)
Table 23. Latin America Branded Generics Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Branded Generics Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Branded Generics Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Branded Generics Sales by Company (2018-2024) & (K MT)
Table 27. Global Branded Generics Sales Share by Company (2018-2024)
Table 28. Global Branded Generics Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Branded Generics Revenue Share by Company (2018-2024)
Table 30. Global Market Branded Generics Price by Company (2018-2024) & (USD/MT)
Table 31. Global Branded Generics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Branded Generics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Branded Generics as of 2022)
Table 34. Date of Key Manufacturers Enter into Branded Generics Market
Table 35. Key Manufacturers Branded Generics Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Branded Generics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Branded Generics Sales by Region (2018-2024) & (K MT)
Table 39. Global Branded Generics Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Branded Generics Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Branded Generics Sales Market Share in Value by Region (2018-2024)
Table 42. Global Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Branded Generics Sales by Region (2024-2029) & (K MT)
Table 44. Global Branded Generics Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Branded Generics Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Branded Generics Sales Market Share in Value by Region (2024-2029)
Table 47. Global Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 48. Global Branded Generics Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Branded Generics Sales by Application (2018-2024) & (K MT)
Table 50. Global Branded Generics Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Branded Generics Sales Market Share in Value by Application (2018-2024)
Table 53. Global Branded Generics Price by Application (2018-2024) & (USD/MT)
Table 54. Global Branded Generics Sales by Application (2024-2029) & (K MT)
Table 55. Global Branded Generics Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Branded Generics Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Branded Generics Sales Market Share in Value by Application (2024-2029)
Table 58. Global Branded Generics Price by Application (2024-2029) & (USD/MT)
Table 59. North America Branded Generics Sales by Application (2018-2024) (K MT)
Table 60. North America Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Branded Generics Sales by Application (2018-2024) (K MT)
Table 62. Europe Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Branded Generics Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Branded Generics Sales by Application (2018-2024) (K MT)
Table 66. Latin America Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Branded Generics Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Branded Generics Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Branded Generics Sales by Country (2018-2024) & (K MT)
Table 70. North America Branded Generics Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Branded Generics Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Branded Generics Sales Market Share in Value by Country (2018-2024)
Table 73. North America Branded Generics Sales by Country (2024-2029) & (K MT)
Table 74. North America Branded Generics Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Branded Generics Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Branded Generics Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Branded Generics Sales by Country (2018-2024) & (K MT)
Table 78. Europe Branded Generics Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Branded Generics Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Branded Generics Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Branded Generics Sales by Country (2024-2029) & (K MT)
Table 82. Europe Branded Generics Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Branded Generics Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Branded Generics Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Branded Generics Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Branded Generics Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Branded Generics Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Branded Generics Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Branded Generics Sales by Region (2024-2029) & (K MT)
Table 90. Asia-Pacific Branded Generics Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Branded Generics Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Branded Generics Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Branded Generics Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Branded Generics Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Branded Generics Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Branded Generics Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Branded Generics Sales by Country (2024-2029) & (K MT)
Table 98. Latin America Branded Generics Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Branded Generics Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Branded Generics Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Branded Generics Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Branded Generics Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Branded Generics Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Branded Generics Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Branded Generics Sales by Country (2024-2029) & (K MT)
Table 106. Middle East and Africa Branded Generics Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Branded Generics Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Branded Generics Sales Market Share in Value by Country (2024-2029)
Table 109. Mylan NV Company Information
Table 110. Mylan NV Introduction and Business Overview
Table 111. Mylan NV Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. Mylan NV Branded Generics Product
Table 113. Mylan NV Recent Development
Table 114. Novartis AG Company Information
Table 115. Novartis AG Introduction and Business Overview
Table 116. Novartis AG Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Novartis AG Branded Generics Product
Table 118. Novartis AG Recent Development
Table 119. Eva Pharmaceutical Industries Company Information
Table 120. Eva Pharmaceutical Industries Introduction and Business Overview
Table 121. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Eva Pharmaceutical Industries Branded Generics Product
Table 123. Eva Pharmaceutical Industries Recent Development
Table 124. Pfizer Company Information
Table 125. Pfizer Introduction and Business Overview
Table 126. Pfizer Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Pfizer Branded Generics Product
Table 128. Pfizer Recent Development
Table 129. Sun Pharmaceutical Industries Company Information
Table 130. Sun Pharmaceutical Industries Introduction and Business Overview
Table 131. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Sun Pharmaceutical Industries Branded Generics Product
Table 133. Sun Pharmaceutical Industries Recent Development
Table 134. Aspen Pharmacare Holding Company Information
Table 135. Aspen Pharmacare Holding Introduction and Business Overview
Table 136. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Aspen Pharmacare Holding Branded Generics Product
Table 138. Aspen Pharmacare Holding Recent Development
Table 139. Abbott Laboratories Company Information
Table 140. Abbott Laboratories Introduction and Business Overview
Table 141. Abbott Laboratories Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Abbott Laboratories Branded Generics Product
Table 143. Abbott Laboratories Recent Development
Table 144. Bausch Health Company Information
Table 145. Bausch Health Introduction and Business Overview
Table 146. Bausch Health Branded Generics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Bausch Health Branded Generics Product
Table 148. Bausch Health Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Branded Generics Market Trends
Table 152. Branded Generics Market Drivers
Table 153. Branded Generics Market Challenges
Table 154. Branded Generics Market Restraints
Table 155. Branded Generics Distributors List
Table 156. Branded Generics Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Branded Generics Product Picture
Figure 2. Global Branded Generics Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Branded Generics Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Branded Generics Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Parenteral
Figure 8. Global Parenteral Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of Topical
Figure 10. Global Topical Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Global Branded Generics Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Branded Generics Sales Market Share by Type in 2022 & 2029
Figure 15. North America Branded Generics Sales Market Share in Volume by Type in 2022
Figure 16. North America Branded Generics Sales Market Share in Value by Type in 2022
Figure 17. Europe Branded Generics Sales Market Share in Volume by Type in 2022
Figure 18. Europe Branded Generics Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Branded Generics Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Branded Generics Sales Market Share in Value by Type in 2022
Figure 21. Latin America Branded Generics Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Branded Generics Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Branded Generics Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Branded Generics Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Branded Generics Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Branded Generics Revenue in 2022
Figure 27. Branded Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Oncology
Figure 29. Global Oncology Sales YoY Growth (2018-2029) & (K MT)
Figure 30. Product Picture of Cardiovascular Diseases
Figure 31. Global Cardiovascular Diseases Sales YoY Growth (2018-2029) & (K MT)
Figure 32. Product Picture of Diabetes
Figure 33. Global Diabetes Sales YoY Growth (2018-2029) & (K MT)
Figure 34. Product Picture of Neurology
Figure 35. Global Neurology Sales YoY Growth (2018-2029) & (K MT)
Figure 36. Product Picture of Gastrointestinal Diseases
Figure 37. Global Gastrointestinal Diseases Sales YoY Growth (2018-2029) & (K MT)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2029) & (K MT)
Figure 40. Global Branded Generics Sales by Application (2018-2029) & (US$ Million)
Figure 41. Global Branded Generics Sales Market Share by Application in 2022 & 2029
Figure 42. North America Branded Generics Sales Market Share in Volume by Application in 2022
Figure 43. North America Branded Generics Sales Market Share in Value by Application in 2022
Figure 44. Europe Branded Generics Sales Market Share in Volume by Application in 2022
Figure 45. Europe Branded Generics Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Branded Generics Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Branded Generics Sales Market Share in Value by Application in 2022
Figure 48. Latin America Branded Generics Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Branded Generics Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Branded Generics Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Branded Generics Manufacturing Cost Structure
Figure 53. Branded Generics Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries